Forex Today: Markets advance on stimulus hopes, vaccine optimism outweighs virus strain concerns

Here is what you need to know on Monday, January 25:

Markets are on the rise as the Biden administration pushes for stimulus and ahead of the Fed decision. The dollar is on the back foot while oil is higher and gold is stable.

President Joe Biden is facing some bipartisan pushback for his $1.9 trillion fiscal stimulus bill, only a month after Congress passed a $900 billion package. COVID-19 relief elements receive support while other topics suggest a raise to the minimum wage are questioned. Nevertheless, reports in Washington suggest that the administration is set to advance the full proposal. Headlines are set to move markets.

Tensions are rising ahead of the Federal Reserve's decision on Wednesday. The bank is set to leave rates unchanged and rule out any early tapering of its bond-buying scheme.

Coronavirus: Global cases are nearing 100 million and fears of strains are competing with hopes that the vaccine provides an exit from the crisis. The US is set to enact a travel ban on South Africa, fearing the variant. The UK's controversial policy of delaying the second vaccine jab could be copied by other countries and France is set to enter a new nationwide lockdown. Johnson and Johnson are set to report results from its one-shot covid vaccine during the week.

Coronavirus: Statistics, herd immunity, vaccine calendar and impact on financial markets and currencies

The euro is also edging up against the dollar, albeit lagging behind its peers. The German IFO Business Climate is set to edge lower in the report for January. Christine Lagarde, President of the European Central Bank, is scheduled to speak later in the day after leaving the bank's policy unchanged last week.

Cryptocurrencies: Ethereum stood out with a surge to new highs near $1,500, while Bitcoin is trading around $33,000.

Is gold about to shine again? Talking havens, currencies, markets as the Biden era begins

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.